Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases

    Ying Liu
    Ying Liu

    Frontiers in Endocrinology, 2019.

    Cited by: 0|Bibtex|Views0|Links

    Abstract:

    Cardiometabolic diseases encompass those affecting the heart and vasculature as well as other metabolic problems, such as insulin resistance, diabetes, and non-alcoholic fatty liver disease. These diseases tend to have common risk factors, one of which is impaired adiponectin action. This may be due to reduced bioavailability of the hormo...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments